Anthony Johnson
Vice President
Early Clinical Development
AstraZeneca
United Kingdom
Biography
Dr.Anthony is a Fellow at Homerton College, University of Cambridge and, prior to AstraZeneca, was a Board Director for Cardioxyl (2012-2015) and Rgenix (2014-2015), and a Venture Partner at OrbiMed Advisors, a global healthcare-only investment firm (2012-2013).He has served as Vice President on the executive team of the Center of Excellence for Drug Discovery responsible for multiple therapeutic areas at GlaxoSmithKline (2001-2006). Complementing his substantial healthcare industry leadership experience, he has 18 years of broad clinical practice experience. In addition,he has published extensively in and served as an external reviewer for several international, peer reviewed journals, has attracted national peer-reviewed research grant funding in multiple countries and has broad teaching experience including invited presentations at numerous scientific and medical meetings.
Research Interest
Drug Discovery, Biomedical/Medical Engineering
